What can new glucose-lowering SGLT2-inhibitors add to CV risk management in diabetes?

What can new glucoselowering SGLTinhibitors add to CV risk management in diabetes
Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying PACE-CME…
but how about a more personalized experience?

Register for free